Eliglustat: Genotype-Directed Drug Interaction Management

March 2018

John R. Horn, PharmD, FCCP and Philip D. Hansten, PharmD

References:

1. Belmatoug N, Di Rocco M, Fraga C, Giraldo P, Hughes D, Lukina E, et al. Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe. Eur J Intern Med. 2017;37:25-32.

2. Eliglustat (Cerdelga) Product Information, Gnezyme Ireland, Ltd., 2014.